Toggle Summary 19 Mar. 2024
JPL's announce EGM to be held on 16 April 2024 for the purpose of considering and, if thought fit, passing resolutions in respect to the JPL's proposed terms of remuneration and the JPL's remuneration and disbursements for the period from 22 September 2022 to 30 September 2023. Further details regarding the proposals are set out in the i) Notice of EGM ii) Proxy Card iii) Proxy Statement and iv) Rules of Conduct . Note that only verified shareholders will be able to vote at the EGM.
Toggle Summary 08 Mar. 2024
JPLs release copy of their Seventh Report to the Grand Court of the Cayman Islands
Toggle Summary 01 Dec. 2023
JPLs release copy of their Sixth Report to the Grand Court of the Cayman Islands
Toggle Summary 04 Sep. 2023
JPLs release copy of their Fifth Report to the Grand Court of the Cayman Islands
Toggle Summary 01 Jun. 2023
JPLs release copy of their Fourth Report to the Grand Court of the Cayman Islands
Toggle Summary 02 Mar. 2023
JPLs release copy of their Third Report to the Grand Court of the Cayman Islands
Toggle Summary 02 Dec. 2022
JPLs release copy of their Second Report to the Grand Court of the Cayman Islands
Toggle Summary 31 Oct. 2022
JPLs release copy of their First Report to the Grand Court of the Cayman Islands
Toggle Summary 26 Sep. 2022
Press Release in respect of the JPLs appointment
Toggle Summary 16 Aug. 2022
Global Cord Blood Corporation Files Annual Report on Form 20-F
Toggle Summary 06 Jul. 2022
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
Toggle Summary 05 Jul. 2022
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Toggle Summary 16 Jun. 2022
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
Toggle Summary 16 Jun. 2022
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
Toggle Summary 10 May. 2022
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
Toggle Summary 29 Apr. 2022
Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights
Toggle Summary 28 Feb. 2022
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
Toggle Summary 23 Feb. 2022
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
